Tony Fouweather

Statistician

Population Health Sciences Institute

Biography

Contact

Email: tony.fouweather@ncl.ac.uk
Telephone: +44 (0) 191 208 3822
Address: Population Health Sciences Institute, 4th Floor Ridley Building 1, Queen Victoria Road, Newcastle upon Tyne NE1 7RU, UK

Publications

Quickly discover relevant content by filtering publications.

O'Hara J, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, Carding P, Karagama Y, Wood R, Wilson JA (2021). Use of proton pump inhibitors to treat persistent throat symptoms: Multicentre, double blind, randomised, placebo controlled trial. BMJ 2021; 372:m4903.

Wilson JA, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, Carding P, Karagama Y, Harries M, Ball S, Khwaja S, Costello D, Wood R, Lecouturier J, O'Hara J (2021). Lansoprazole for persistent throat symptoms in secondary care: The TOPPITS RCT. Health Technol Assess 2021; 25:1-118.

Alderson H, Kaner E, McColl E, Howel D, Fouweather T, McGovern R, Copello A, Brown H, McArdle P, Smart D, Brown R, Lingam R (2020). A pilot feasibility randomised controlled trial of two behaviour change interventions compared to usual care to reduce substance misuse in looked after children and care leavers aged 12-20 years: The SOLID study. PLoS ONE 2020; 15:e0238286.

Alderson H, Kaner E, Brown R, Howel D, McColl E, Smart D, Copello A, Fouweather T, McGovern R, Brown H, McArdle P, Lingam R (2020). Behaviour change interventions to reduce risky substance use and improve mental health in children in care: The SOLID three-arm feasibility RCT. Public Health Res 2020; 8.

Adams N, Skelton DA, Howel D, Bailey C, Lampitt R, Fouweather T, Gray J, Coe D, Wilkinson J, Gawler S, de Jong LD, Waterman H, Deary V, Clarke M, Parry SW (2018). Feasibility of trial procedures for a randomised controlled trial of a community based group exercise intervention for falls prevention for visually impaired older people: The VIOLET study. BMC Geriatr 2018; 18:307.

Yadegarfar ME, Jagger C, Duncan R, Fouweather T, Hanratty B, Parker S, Robinson L (2018). Use of primary care and other healthcare services between age 85 and 90 years: Longitudinal analysis of a single-year birth cohort, the Newcastle 85+ study. BMJ Open 2018; 8:e019218.

Brass D, Fouweather T, Stocken DD, MacDonald C, Wilkinson J, Lloyd J, Farr PM, Reynolds NJ, Hampton PJ (2017). An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen–ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema. Brit J Dermatol 2018; 179:63-71.

Alderson H, McGovern R, Brown R, Howel D, Becker F, Carr L, Copello A, Fouweather T, Kaner E, McArdle P, McColl E, Shucksmith J, Steele A, Vale L, Lingam R (2017). Supporting Looked After Children and Care Leavers In Decreasing Drugs, and alcohol (SOLID): Protocol for a pilot feasibility randomised controlled trial of interventions to decrease risky substance use (drugs and alcohol) and improve mental health of look. Pilot Feasibility Stud 2017; 3:25.

Bell GM, Anderson AE, Diboll J, Reece R, Eltherington O, Harry RA, Fouweather T, MacDonald C, Chadwick T, McColl E, Dunn J, Dickinson AM, Hilkens CMU, Isaacs JD (2017). Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Ann Rheum Dis 2017; 76:227-34.

Adams N, Skelton D, Bailey C, Howel D, Coe D, Lampitt R, Wilkinson J, Fouweather T, de Jong LD, Gawler S, Deary V, Gray J, Waterman H, Parry SW (2016). Visually Impaired OLder people's Exercise programme for falls prevenTion (VIOLET): A feasibility study. BMJ Open 2016; 6:e011996.

Watson G, O'Hara J, Carding P, Lecouturier J, Stocken D, Fouweather T, Wilson J (2016). TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. Trials 2016; 17:175.

Jagger C, Matthews FE, Wohland P, Fouweather T, Stephan BCM, Robinson L, Arthur A, Brayne C (2016). A comparison of health expectancies over two decades in England: Results of the Cognitive Function and Ageing Study I and II. Lancet 2016; 387:779-86.

Pinder EM, Rostron AJ, Hellyer TP, Ruchaud-Sparagano M-H, Scott J, Macfarlane JG, Wiscombe S, Widdrington JD, Allen T, Roy AI, Linnett VC, Baudouin SV, Wright SE, Chadwick T, Fouweather A, Bowett S, Parker J, Corris PA, McAuley DF, Morris AC, Simpson AJ (2016). Randomised controlled trial of granulocyte macrophage colony stimulating factor in critically ill patients with impaired neutrophil function. Am J Resp Crit Care 2016; 201:A2727.

Brass D, Farr P, Reynolds N, Stocken D, MacDonald C, Wahie S, Weatherhead S, Wilkinson J, Lloyd J, Hill S, Fouweather T, Hampton P (2015). An observer-blinded randomized controlled pilotstudy comparing localised psoralen–ultraviolet A with localized narrowband ultraviolet B for thetreatment of hand eczema. Brit J Dermatol 2015; 173:11-3.

Fouweather T, Gillies C, Wohland P, Van Oyen H, Nusselder W, Robine J-M, Cambois E, Jagger C, for the JA: EHLEIS Team (2015). Comparison of socio-economic indicators explaining inequalities in Healthy Life Years at age 50 in Europe: 2005 and 2010. Eur J Public Health 2015; 25:978–83.

Ashby-Mitchell K, Jagger C, Fouweather T, Anstey KJ (2015). Life expectancy with and without cognitive impairment in seven Latin American and Caribbean countries. PLoS ONE 2015; 10:e0121867.

Berger N, Van Oyen H, Cambois E, Fouweather T, Jagger C, Nusselder W, Robine J-M (2015). Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries. BMC Med Res Methodol 2015; 15:1.

See all publications